HER2FISH results in breast cancers with increased CEN17 signals using alternative chromosome 17 probes - reclassifying cases in the equivocal category-Reference-Cited by-同舟云学术

HER2FISH results in breast cancers with increased CEN17 signals using alternative chromosome 17 probes - reclassifying cases in the equivocal category

Published:2017-07-06 Issue:4 Volume:71 Page:610-625
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Holzschuh Maria-Anna¹,Czyz Zbigniew²,Hauke Sven³,Inwald Elisabeth C¹,Polzer Bernhard²,Brockhoff Gero¹^ORCID

Affiliation:

1. Department of Gynaecology and Obstetrics; University Medical Centre Regensburg; Regensburg Germany

2. Project Group ‘Personalized Tumour Therapy’; Fraunhofer Institute for Toxicology and Experimental Medicine; Regensburg Germany

3. ZytoVision GmbH; Bremerhaven Germany

Funder

ZytoVision GmbH

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.13253/fullpdf

Reference35 articles.

1. Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review;Dawood;J. Clin. Oncol.,2010

2. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy;Ross;Oncologist,1998

3. Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization;Isola;Clin. Cancer Res.,2004

4. HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity;Hanna;Mod. Pathol.,2014

5. HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial;Perez;J. Clin. Oncol.,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor Mice;International Journal of Molecular Sciences;2024-07-08

2. Molecular testing in breast cancer;Diagnostic Molecular Pathology;2024

3. Complementary Tumor Diagnosis by Single Cell–Based Cytogenetics Using Multi‐marker Fluorescence In Situ Hybridization (mFISH);Current Protocols;2023-11

4. mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease;International Journal of Cancer;2021-12-28

5. Current and potential immunohistochemical biomarkers for prognosis and therapeutic stratification of breast carcinoma;Seminars in Cancer Biology;2021-07